Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

PEPG PepGen Inc

16,42

-0,95 (-5,47%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:00:01

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

PepGen (NASDAQ:PEPG)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more PepGen Charts.

PepGen (NASDAQ:PEPG)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more PepGen Charts.

News PepGen Inc

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 13 Juni 2024 (5 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 11 Juni 2024 (1 Woche vor) • Edgar (US Regulatory)

PepGen Announces Executive Team Promotions
Dienstag 11 Juni 2024 (1 Woche vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 7 Juni 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 5 Juni 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 18 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 17 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 14 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

PepGen Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Dienstag 14 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 14 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

PepGen to Participate in Upcoming Investor Conferences
Mittwoch 13 März 2024 (3 Monate vor) • GlobeNewswire Inc.

PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
Mittwoch 13 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere PepGen Inc News-Artikel

BNP Paribas Issuance

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen